CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Bear Stearns 20th Annual Healthcare Conference on Tuesday, September 11, 2007, at 2:30 p.m. ET at The Grand Hyatt New York.
